JFG
QNCX icon

JDM Financial Group’s Quince Therapeutics QNCX Stock Holding History

JDM Financial Group’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34 Hold
2
– – ﹤0.01% 317
2025
Q4 		$1.14K Hold
2
– – ﹤0.01% 243
2025
Q3 		$554 Hold
2
– – ﹤0.01% 279
2025
Q2 		$561 Hold
2
– – ﹤0.01% 258
2025
Q1 		$452 Hold
2
– – ﹤0.01% 293
2024
Q4 		$636 Hold
2
– – ﹤0.01% 318
2024
Q3 		$264 Hold
2
– – ﹤0.01% 403
2024
Q2 		$255 Hold
2
– – ﹤0.01% 221
2024
Q1 		$360 Hold
2
– – ﹤0.01% 211
2023
Q4 		$357 Hold
2
– – ﹤0.01% 208
2023
Q3 		$381 Hold
2
– – ﹤0.01% 207
2023
Q2 		$512 Hold
2
– – ﹤0.01% 207
2023
Q1 		$530 Hold
2
– – ﹤0.01% 216
2022
Q4 		$217 Buy
+2
New +$334 ﹤0.01% 215

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JDM Financial Group's QNCX Position: Q1 2026 in Review

JDM Financial Group held its Quince Therapeutics (QNCX) position steady in Q1 2026 at 2 shares worth $34. The position accounts for ﹤0.01% of the portfolio, ranked #317.

JDM Financial Group first reported a position in QNCX in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.14K in Q4 2025. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • JDM Financial Group held 2 shares of Quince Therapeutics worth $34 as of Q1 2026.
  • JDM Financial Group left its Quince Therapeutics share count unchanged in Q1 2026.
  • Quince Therapeutics made up ﹤0.01% of JDM Financial Group's portfolio in Q1 2026, its #317 holding.
  • JDM Financial Group first reported a position in Quince Therapeutics in Q4 2022 and has held it in 14 quarters since.
  • JDM Financial Group's Quince Therapeutics position peaked at $1.14K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on JDM Financial Group's 13F filing for Q1 2026, filed 21 May 2026.